Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial)

Fulltext present in this item

Fulltext: 199534.pdf

Format: PDF

Description: publisher's version

Title:	Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial)
Author(s):	Korjian, S.; Braunwald, Eugene; Daaboul, Y.; Mi, Michael; Bhatt, Deepak L.; Verheugt, F.W.A. ; Plotnikov, A.N.; Gibson, C. Michael
Publication year:	2018
Source:	American Journal of Cardiology, vol. 122, iss. 11, (2018), pp. 1896-1901
ISSN:	0002-9149
DOI:	https://doi.org/10.1016/j.amjcard.2018.08.034
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/199534
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences
Organization:	Cardiology
Journal title:	American Journal of Cardiology
Volume:	vol. 122
Issue:	iss. 11
Page start:	p. 1896
Page end:	p. 1901

Faculty of Medical Sciences [73900]
Open Access publications [56925]
Freely accessible full text publications
Electronic publications [87458]
Freely accessible full text publications plus those not yet available due to embargo
Academic publications [187737]
Academic output Radboud University